Quotient Bioresearch is a provider of early stage and specialist drug development services to pharmaceutical, biotechnology and medical devices clients worldwide. 

Their adaptive early stage and specialist drug development services provide tailored solutions, delivered through state-of-the-art technologies and underpinned by unparalleled medical, chemical and biological expertise. This flexible, science driven approach ensures the highest quality service to support and accelerate the development of clients pioneering medicines and products.

Quotient offer an extensive range of capabilities which span chemistry and metabolism, bioanalytical sciences and clinical services, provided independently or integrated into tailored work programmes. These are driven by scientific expertise and delivered using flexible platforms including:

• ¹⁴C enabled drug development using our unique Synthesis-to-Clinic™ platform
• Phase I clinical studies using our Translational Pharmaceutics™ platform